pharmaceutical-investing Zosano Announces Publication of Positive Data on Qtrypta’s™ Potential as an Acute Treatment for Patients with Difficult-to-Treat Migraines
pharmaceutical-investing Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment
